Source: PharmaTech

Novum: Novum Selects OmniComm as Strategic EDC Partner

Novum Pharmaceutical Research Services has selected TrialMaster electronic data capture technology from OmniComm Systems, Inc to support their clinical research. Novum with the use of TrialMaster will conduct more than 200 research studies annually due to the flexibility, ease of

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
Christopher H. Chamberlain's photo - CEO of Novum Pharmaceutical Research Services, Inc.

CEO

Christopher H. Chamberlain

CEO Approval Rating

82/100

Read more